AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CapsoVision, Inc. Common Stock
XNAS · usd
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG00KHZ9QK0
6.99▲ 0.19 (2.79%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
6.80
Day's Range
6.66 – 7.18
52-Week Range
4.50 – 15.37
Volume
320.2K
Avg Volume
220.4K
Share Statistics
Shares Outstanding
Employees
99
Exchange
XNAS
Listed
2025-07-02
Share count as of August 12, 2026

CapsoVision, Inc. Common Stock (CV) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about CapsoVision, Inc. Common Stock (CV)
What is CapsoVision, Inc. Common Stock's Market Cap?
CapsoVision, Inc. Common Stock's Market Cap is $349.8M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Price / Sales?
CapsoVision, Inc. Common Stock's Price / Sales is 25.2×, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Revenue (TTM)?
CapsoVision, Inc. Common Stock's Revenue (TTM) is $13.9M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Net Income (TTM)?
CapsoVision, Inc. Common Stock's Net Income (TTM) is -$29.8M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's EBITDA?
CapsoVision, Inc. Common Stock's EBITDA is -$29.9M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Diluted EPS (TTM)?
CapsoVision, Inc. Common Stock's Diluted EPS (TTM) is -0.60, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's EBITDA Margin?
CapsoVision, Inc. Common Stock's EBITDA Margin is -215.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CVAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Net revenue
YoY growth+9.9%+0.3%+13.5%+19.3%
Costs of revenue
Gross profit
% of revenue51.4%47.6%49.9%54.1%
Selling and marketing
Research and development
General and administrative
Total operating expenses
% of revenue259.4%301.6%240.4%280.8%
Operating loss
% of revenue-208.1%-254.0%-190.5%-226.7%
Interest income, net
Other non-operating income (expense), net
Total non-operating income, net
Loss before income taxes
Provision for income taxes
Net loss
% of revenue-205.4%-251.9%-188.7%-223.9%
Net loss per share - basic (in dollars per share)—
Net loss per share - diluted (in dollars per share)—